Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

21 results
Display

ASCO 2019 meeting review

Diver E, Dorigo O, Berek J

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment

Kwon JS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
After the Laparoscopic Approach to Cervical Cancer (LACC) trial: Korean Society of Gynecologic Oncology (KSGO) survey

Kim M, Kim YB, Kim JW

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How to use immune checkpoint inhibitor in ovarian cancer?

Park J, Lee JY, Kim S

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Letter to editor in response to: prior uterine myoma and risk of ovarian cancer: a population-based case-control study

Oxley SG, Sirkeci F, Odejinmi F

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement

Kim M, Kong TW, Kim S, Kim SC, Kim YB, Kim JW, Park JY, Suh DH, Shim SH, Lee KH, Lee SJ, Lee JK, Lim MC

On the basis of emerging data and the current understanding of minimally invasive surgery (MIS) for radical hysterectomy (RH) in women with cervical cancer, the Korean Society of Gynecologic Oncology,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Aromatase inhibition in ovarian cancer: repeated signals of efficacy but tools for patient selection remain elusive

Gourley C

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Erratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancer

Tozzi R, Casarin J, Baysal A, Valenti G, Kilic Y, Majd HS, Morotti M

The original article by Tozzi et al. entitled, “Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Transperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 steps

Heinemann , Masquin I, Blache G, Sabiani L, Jauffret C, Houvenaeghel G, Lambaudie

OBJECTIVE: Para-aortic lymphadenectomy was the cornerstone of gynecologic oncology surgery. In endometrial cancer, the quality of para-aortic lymphadenectomy had direct impact on survival of patient. The launch of robot assisted...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Response to comment on: prior uterine myoma and risk of ovarian cancer: a population-based case-control study

Huang CC, Lin CH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The efficacy of modified Swede Colposcopic Index in prediction of high-grade lesion and cancer of cervix

Rodpenpear N, Pataradool K

OBJECTIVE: To evaluate the efficacy of modified Swede Colposcopic Index (MSCI) to predict high-grade lesion and cancer of cervix (CIN2+, cervical intraepithelial neoplasia grade 2 or worse) in women with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic value of post-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis

Kim YJ, Han S, Kim YS, Nam JH

OBJECTIVES: To perform a systematic review and meta-analysis of the prognostic value of post-treatment 18F-fluorodeoxyglucose positron emission tomography (¹⁸F-FDG PET) in uterine cervical cancer patients treated with radiotherapy (RT) with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression

Kok PS, Beale P, O'Connell , Grant P, Bonaventura T, Scurry J, Antill Y, Goh J, Sjoquist K, DeFazio A, Mapagu C, Amant F, Friedlander M, on behalf of the PARAGON Investigators

OBJECTIVE: A subset of patients with recurrent ovarian cancer (ROC) may benefit from antiestrogen therapy with higher response rates reported in tumors that are strongly estrogen receptor (ER)-positive (ER+). PARAGON...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Involved-field radiation therapy for selected cases of recurrent ovarian cancer

Kim N, Chang JS, Kim SW, Kim GM, Lee JY, Kim YB

OBJECTIVES: In our institutional experience, involved-field radiation therapy (IFRT) yields favorable outcomes in patients with recurrent epithelial ovarian cancer (EOC). This retrospective study aimed to investigate the clinical benefits of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pseudolaric acid B inhibits PAX2 expression through Wnt signaling and induces BAX expression, therefore promoting apoptosis in HeLa cervical cancer cells

Guan D, Li C, Lv X, Yang Y

OBJECTIVES: Pseudolaric acid B (PAB) has been shown to inhibit the growth of various tumor cells, but the molecular details of its function are still unknown. This study investigated the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study

Ørtoft G, Lausten-Thomsen L, Høgdall C, Hansen ES, Dueholm M

OBJECTIVE: To evaluate the effect of lymph-vascular space invasion (LVSI) on location of recurrences in Danish patients with endometrial cancer. METHODS: This national cohort study (2005–2012) included 4,380 radically operated patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study

Reijnen C, Visser NC, Kasius JC, Boll D, Geomini PM, Ngo H, Van Hamont D, Pijlman BM, Vos MC, Bulten J, Snijders M, Massuger L, Pijnenborg JM

OBJECTIVES: The global obesity epidemic has great impact on the prevalence of low-grade endometrial carcinoma. The preoperative tumor serum marker cancer antigen 125 (CA-125) might contribute to improved identification of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling

Shin HY, Lee B, Hwang SH, Lee DO, Sung NY, Park JY, Jun JK

OBJECTIVE: Human papillomavirus testing by self-sampling and urine sampling might be alternatives to Papanicolaou test (Pap test) for cervical cancer screening (CCS), and may increase compliance and adherence thereto. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Overexpression of HER2/HER3 and clinical feature of ovarian cancer

Chung YW, Kim S, Hong JH, Lee JK, Lee NW, Lee YS, Song JY

OBJECTIVES: Human epidermal growth factor receptor-2 (HER2) and 3 (HER3) belong to the epidermal growth factor receptor (EGFR) family of transmembrane receptor tyrosine kinases. In this study, we assessed HER2/HER3...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prior uterine myoma and risk of ovarian cancer: a population-based case-control study

Tseng JJ, Huang CC, Chiang HY, Chen YH, Lin CH

OBJECTIVE: Uterine myoma which results in the magnitude of ovarian cancer remains uncertain. This study aimed to assess the association between women with previous uterine myoma and the risk of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr